News & Analysis on Clinical Trial Services & Contract Research And Development
NextPharma: acquisition of two former Lonza facilities
By Jenni Spinner
- Last updated on
Lonza has divested two of its former sites to NextPharma, a European CDMO. The two sites are based in Ploermel, France; and Edinburgh, UK.
Peter Burema, CEO of NextPharma, said, “We are very excited at adding two new centers of excellence, at Ploermel and Edinburgh, to NextPharma’s manufacturing network, allowing us to further broaden our technology offering for both our existing and new customers.”